SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Maestre Gladys E.)
 

Sökning: WFRF:(Maestre Gladys E.) > Outcome-Driven Thre...

  • Cheng, Yi-BangShanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R China (författare)

Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension

  • Artikel/kapitelEngelska2019

Förlag, utgivningsår, omfång ...

  • 2019
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-395430
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-395430URI
  • https://doi.org/10.1161/HYPERTENSIONAHA.119.13512DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • The new American College of Cardiology/American Heart Association guideline reclassified office blood pressure and proposed thresholds for ambulatory blood pressure (ABP). We derived outcome-driven ABP thresholds corresponding with the new office blood pressure categories. We performed 24-hour ABP monitoring in 11 152 participants (48.9% women; mean age, 53.0 years) representative of 13 populations. We determined ABP thresholds resulting in multivariable-adjusted 10-year risks similar to those associated with elevated office blood pressure (120/80 mm Hg) and stages 1 and 2 of office hypertension (130/80 and 140/90 mm Hg). Over 13.9 years (median), 2728 (rate per 1000 person-years, 17.9) people died, 1033 (6.8) from cardiovascular disease; furthermore, 1988 (13.8), 893 (6.0), and 795 (5.4) cardiovascular and coronary events and strokes occurred. Using a composite cardiovascular end point, systolic/diastolic outcome-driven thresholds indicating elevated 24-hour, daytime, and nighttime ABP were 117.9/75.2, 121.4/79.6, and 105.3/66.2 mm Hg. For stages 1 and 2 ambulatory hypertension, thresholds were 123.3/75.2 and 128.7/80.7 mm Hg for 24-hour ABP, 128.5/79.6 and 135.6/87.1 mm Hg for daytime ABP, and 111.7/66.2 and 118.1/72.5 mm Hg for nighttime ABP. ABP thresholds derived from other end points were similar. After rounding, approximate thresholds for elevated 24-hour, daytime, and nighttime ABP were 120/75, 120/80, and 105/65 mm Hg, and for stages 1 and 2, ambulatory hypertension 125/75 and 130/80 mm Hg, 130/80 and 135/85 mm Hg, and 110/65 and 120/70 mm Hg. Outcome-driven ABP thresholds corresponding to elevated blood pressure and stages 1 and 2 of hypertension are similar to those proposed by the current American College of Cardiology/American Heart Association guideline.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Thijs, LutgardeUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium (författare)
  • Zhang, Zhen-YuUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium (författare)
  • Kikuya, MasahiroTeikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan (författare)
  • Yang, Wen-YiUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium (författare)
  • Melgarejo, Jesus D.Univ Zulia, Lab Neurociencias, Maracaibo, Venezuela; Univ Zulia, Inst Enfermedades Cardiovasc, Maracaibo, Venezuela (författare)
  • Boggia, JoseUniv Republica, Hosp Clin, Ctr Nefrol, Montevideo, Uruguay; Univ Republica, Hosp Clin, Dept Fisiopatol, Montevideo, Uruguay (författare)
  • Wei, Fang-FeiUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium (författare)
  • Hansen, Tine W.Steno Diabet Ctr, Gentofte, Denmark;Ctr Hlth, Gentofte, Capital Region, Denmark (författare)
  • Yu, Cai-GuoUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium (författare)
  • Asayama, KeiTeikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan;Tohoku Inst Management Blood Pressure, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan (författare)
  • Ohkubo, TakayoshiTeikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan;Tohoku Inst Management Blood Pressure, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan (författare)
  • Dolan, EamonStroke & Hypertens Unit, Dublin, Ireland (författare)
  • Stolarz-Skrzypek, KatarzynaJagiellonian Univ, Med Coll, Dept Cardiol Intervent Electrocardiol & Hypertens, Krakow, Poland (författare)
  • Malyutina, SofiaRussian Acad Sci, Inst Internal & Prevent Med, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia (författare)
  • Casiglia, EdoardoUniv Padua, Dept Med, Padua, Italy (författare)
  • Lind, LarsUppsala universitet,Geriatrik,Uppsala Univ, Sect Geriatr, Dept Publ Hlth & Caring Sci, Uppsala, Sweden(Swepub:uu)larslind (författare)
  • Filipovsky, JanCharles Univ Prague, Fac Med, Plzen, Czech Republic (författare)
  • Maestre, Gladys E.Univ Zulia, Lab Neurociencias, Maracaibo, Venezuela; Univ Zulia, Inst Enfermedades Cardiovasc, Maracaibo, Venezuela; Univ Texas Rio Grande Valley, Sch Med, Dept Neurosci, Brownsville, TX USA; Univ Texas Rio Grande Valley, Sch Med, Dept Human Genet, Brownsville, TX USA (författare)
  • Imai, YutakaTohoku Inst Management Blood Pressure, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan (författare)
  • Kawecka-Jaszcz, KalinaJagiellonian Univ, Med Coll, Dept Cardiol Intervent Electrocardiol & Hypertens, Krakow, Poland (författare)
  • Sandoya, EdgardoAsociac Espanola Primera Socorros Mutuos, Montevideo, Uruguay (författare)
  • Narkiewicz, KrzysztofMed Univ Gdansk, Dept Hypertens & Diabetol, Hypertens Unit, Gdansk, Poland (författare)
  • Li, YanShanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R China (författare)
  • O'Brien, EoinUniv Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland (författare)
  • Wang, Ji-GuangShanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R China (författare)
  • Staessen, Jan A.Univ Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium; Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands (författare)
  • Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R ChinaUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Hypertension74:4, s. 776-7830194-911X1524-4563

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy